Tirzepatide — the first dual GIP/GLP-1 medication — posted the strongest trial results in its class (~20% average body-weight loss). Available at Peace Clinic as a full supervised program: genuine pens, labs, titration, follow-up.
Mounjaro activates two gut-hormone pathways: GLP-1 (satiety, slower gastric emptying) plus GIP (improved insulin response and fat metabolism). The combination out-performed single-pathway drugs head-to-head in trials.
It suits people with strong appetite drive and insulin-resistance features — our program pairs it with protein and resistance-exercise guidance so the weight lost is fat, not muscle.
Weekly self-injection with a tiny needle — genuinely easy after the first supervised one.
Appetite quiets within 1–2 weeks; steady loss follows with monthly titration.
Trials show ~20% average at 72 weeks; taper strategy preserves results after.
Monthly cost depends on dose stage; quoted transparently with labs and follow-up included. Beware heavily-discounted online pens — counterfeits are rampant.
Weight-management medication is prescribed and monitored by a doctor. It does not suit everyone and always needs a health assessment first, so it is not something to choose from a comparison table.
The doctor consultation is free — message @peaceclinicth on LINE to book an assessment.
Trials favor Mounjaro for average loss; Wegovy carries the longest cardiovascular data. Your health profile decides — that is the consultation's job.
Mostly yes — nausea clusters at dose steps and settles; slow titration is the fix built into our protocol.
Yes — monthly visit scheduling works for Myawaddy patients; storage guidance provided for the cross-border trip.